Thus, central nervous insulin administration regimens focusing on the sleep period may exert beneficial effects on metabolic health and might even help prevent or treat the brain insulin resistance associated with metabolic disorders (Kullmann et al., 2016). This evidence concerns the gene INS and metabolic disease.